tiprankstipranks
Keros Therapeutics price target lowered to $23 from $63 at Oppenheimer
PremiumThe FlyKeros Therapeutics price target lowered to $23 from $63 at Oppenheimer
2d ago
Keros Therapeutics price target lowered to $32 from $33 at BofA
Premium
The Fly
Keros Therapeutics price target lowered to $32 from $33 at BofA
2d ago
Big banks report Q4 beats, QXO proposes to buy Beacon: Morning Buzz
Premium
The Fly
Big banks report Q4 beats, QXO proposes to buy Beacon: Morning Buzz
3d ago
Keros Therapeutics price target lowered to $63 from $102 at Oppenheimer
PremiumThe FlyKeros Therapeutics price target lowered to $63 from $102 at Oppenheimer
1M ago
Keros Therapeutics downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Buy at Guggenheim
1M ago
Keros Therapeutics price target lowered to $44 from $77 at Scotiabank
Premium
The Fly
Keros Therapeutics price target lowered to $44 from $77 at Scotiabank
1M ago
Keros Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyKeros Therapeutics downgraded to Market Perform from Outperform at William Blair
1M ago
Keros Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Buy at BTIG
1M ago
Morning Movers: Keros Therapeutics plummets after halting TROPOS trial dosing
Premium
The Fly
Morning Movers: Keros Therapeutics plummets after halting TROPOS trial dosing
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100